Serveur d'exploration sur les relations entre la France et l'Australie

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

The immune receptor NOD1 and kinase RIP2 interact with bacterial peptidoglycan on early endosomes to promote autophagy and inflammatory signaling.

Identifieur interne : 003130 ( PubMed/Checkpoint ); précédent : 003129; suivant : 003131

The immune receptor NOD1 and kinase RIP2 interact with bacterial peptidoglycan on early endosomes to promote autophagy and inflammatory signaling.

Auteurs : Aaron T. Irving [Australie] ; Hitomi Mimuro [Japon] ; Thomas A. Kufer [Allemagne] ; Camden Lo [Australie] ; Richard Wheeler [France] ; Lorinda J. Turner [Australie] ; Belinda J. Thomas [Australie] ; Christian Malosse [France] ; Michael P. Gantier [Australie] ; Linda N. Casillas [États-Unis] ; Bartholomew J. Votta [États-Unis] ; John Bertin [États-Unis] ; Ivo G. Boneca [France] ; Chihiro Sasakawa [Japon] ; Dana J. Philpott [Canada] ; Richard L. Ferrero [Australie] ; Maria Kaparakis-Liaskos [Australie]

Source :

RBID : pubmed:24746552

Descripteurs français

English descriptors

Abstract

The intracellular innate immune receptor NOD1 detects Gram-negative bacterial peptidoglycan (PG) to induce autophagy and inflammatory responses in host cells. To date, the intracellular compartment in which PG is detected by NOD1 and whether NOD1 directly interacts with PG are two questions that remain to be resolved. To address this, we used outer membrane vesicles (OMVs) from pathogenic bacteria as a physiological mechanism to deliver PG into the host cell cytosol. We report that OMVs induced autophagosome formation and inflammatory IL-8 responses in epithelial cells in a NOD1- and RIP2-dependent manner. PG contained within OMVs colocalized with both NOD1 and RIP2 in EEA1-positive early endosomes. Further, we provide evidence for direct interactions between NOD1 and PG. Collectively, these findings demonstrate that NOD1 detects PG within early endosomes, thereby promoting RIP2-dependent autophagy and inflammatory signaling in response to bacterial infection.

DOI: 10.1016/j.chom.2014.04.001
PubMed: 24746552


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:24746552

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">The immune receptor NOD1 and kinase RIP2 interact with bacterial peptidoglycan on early endosomes to promote autophagy and inflammatory signaling.</title>
<author>
<name sortKey="Irving, Aaron T" sort="Irving, Aaron T" uniqKey="Irving A" first="Aaron T" last="Irving">Aaron T. Irving</name>
<affiliation wicri:level="1">
<nlm:affiliation>Centre for Cancer Research, Monash Institute of Medical Research, Clayton, VIC 3168, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Centre for Cancer Research, Monash Institute of Medical Research, Clayton, VIC 3168</wicri:regionArea>
<wicri:noRegion>VIC 3168</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Mimuro, Hitomi" sort="Mimuro, Hitomi" uniqKey="Mimuro H" first="Hitomi" last="Mimuro">Hitomi Mimuro</name>
<affiliation wicri:level="4">
<nlm:affiliation>Division of Bacteriology, Department of Infectious Diseases Control, International Research Center for Infectious Diseases, Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Division of Bacteriology, Department of Infectious Diseases Control, International Research Center for Infectious Diseases, Institute of Medical Science, The University of Tokyo, Tokyo 108-8639</wicri:regionArea>
<placeName>
<settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
<settlement type="city">Tokyo</settlement>
</placeName>
<orgName type="university">Université de Tokyo</orgName>
</affiliation>
</author>
<author>
<name sortKey="Kufer, Thomas A" sort="Kufer, Thomas A" uniqKey="Kufer T" first="Thomas A" last="Kufer">Thomas A. Kufer</name>
<affiliation wicri:level="3">
<nlm:affiliation>Institute for Medical Microbiology, Immunology and Hygiene, University of Cologne, Köln 50931, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Institute for Medical Microbiology, Immunology and Hygiene, University of Cologne, Köln 50931</wicri:regionArea>
<placeName>
<region type="land" nuts="1">Rhénanie-du-Nord-Westphalie</region>
<region type="district" nuts="2">District de Cologne</region>
<settlement type="city">Cologne</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Lo, Camden" sort="Lo, Camden" uniqKey="Lo C" first="Camden" last="Lo">Camden Lo</name>
<affiliation wicri:level="1">
<nlm:affiliation>Monash Micro Imaging, Clayton, VIC 3168, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Monash Micro Imaging, Clayton, VIC 3168</wicri:regionArea>
<wicri:noRegion>VIC 3168</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Wheeler, Richard" sort="Wheeler, Richard" uniqKey="Wheeler R" first="Richard" last="Wheeler">Richard Wheeler</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institut Pasteur, Unité Biologie et Génétique de la Paroi Bactérienne, Paris 75015, France; INSERM, Avenir group, Paris 75015, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut Pasteur, Unité Biologie et Génétique de la Paroi Bactérienne, Paris 75015, France; INSERM, Avenir group, Paris 75015</wicri:regionArea>
<wicri:noRegion>75015</wicri:noRegion>
<placeName>
<settlement type="city">Paris</settlement>
<region type="région" nuts="2">Île-de-France</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Turner, Lorinda J" sort="Turner, Lorinda J" uniqKey="Turner L" first="Lorinda J" last="Turner">Lorinda J. Turner</name>
<affiliation wicri:level="1">
<nlm:affiliation>Centre for Innate Immunity and Infectious Diseases, Monash Institute of Medical Research, Clayton, VIC 3168, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Centre for Innate Immunity and Infectious Diseases, Monash Institute of Medical Research, Clayton, VIC 3168</wicri:regionArea>
<wicri:noRegion>VIC 3168</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Thomas, Belinda J" sort="Thomas, Belinda J" uniqKey="Thomas B" first="Belinda J" last="Thomas">Belinda J. Thomas</name>
<affiliation wicri:level="1">
<nlm:affiliation>Centre for Innate Immunity and Infectious Diseases, Monash Institute of Medical Research, Clayton, VIC 3168, Australia; Monash Lung and Sleep, Monash Medical Centre, Clayton, VIC 3168, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Centre for Innate Immunity and Infectious Diseases, Monash Institute of Medical Research, Clayton, VIC 3168, Australia; Monash Lung and Sleep, Monash Medical Centre, Clayton, VIC 3168</wicri:regionArea>
<wicri:noRegion>VIC 3168</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Malosse, Christian" sort="Malosse, Christian" uniqKey="Malosse C" first="Christian" last="Malosse">Christian Malosse</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institut Pasteur, Structural Mass Spectrometry and Proteomics Unit, Paris 75015, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut Pasteur, Structural Mass Spectrometry and Proteomics Unit, Paris 75015</wicri:regionArea>
<wicri:noRegion>75015</wicri:noRegion>
<placeName>
<settlement type="city">Paris</settlement>
<region type="région" nuts="2">Île-de-France</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Gantier, Michael P" sort="Gantier, Michael P" uniqKey="Gantier M" first="Michael P" last="Gantier">Michael P. Gantier</name>
<affiliation wicri:level="1">
<nlm:affiliation>Centre for Cancer Research, Monash Institute of Medical Research, Clayton, VIC 3168, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Centre for Cancer Research, Monash Institute of Medical Research, Clayton, VIC 3168</wicri:regionArea>
<wicri:noRegion>VIC 3168</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Casillas, Linda N" sort="Casillas, Linda N" uniqKey="Casillas L" first="Linda N" last="Casillas">Linda N. Casillas</name>
<affiliation wicri:level="2">
<nlm:affiliation>Pattern Recognition Receptor Discovery Performance Unit, Immuno-Inflammation Therapy Area, GlaxoSmithKline, Collegeville, PA 19426-0989, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Pattern Recognition Receptor Discovery Performance Unit, Immuno-Inflammation Therapy Area, GlaxoSmithKline, Collegeville, PA 19426-0989</wicri:regionArea>
<placeName>
<region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Votta, Bartholomew J" sort="Votta, Bartholomew J" uniqKey="Votta B" first="Bartholomew J" last="Votta">Bartholomew J. Votta</name>
<affiliation wicri:level="2">
<nlm:affiliation>Pattern Recognition Receptor Discovery Performance Unit, Immuno-Inflammation Therapy Area, GlaxoSmithKline, Collegeville, PA 19426-0989, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Pattern Recognition Receptor Discovery Performance Unit, Immuno-Inflammation Therapy Area, GlaxoSmithKline, Collegeville, PA 19426-0989</wicri:regionArea>
<placeName>
<region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Bertin, John" sort="Bertin, John" uniqKey="Bertin J" first="John" last="Bertin">John Bertin</name>
<affiliation wicri:level="2">
<nlm:affiliation>Pattern Recognition Receptor Discovery Performance Unit, Immuno-Inflammation Therapy Area, GlaxoSmithKline, Collegeville, PA 19426-0989, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Pattern Recognition Receptor Discovery Performance Unit, Immuno-Inflammation Therapy Area, GlaxoSmithKline, Collegeville, PA 19426-0989</wicri:regionArea>
<placeName>
<region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Boneca, Ivo G" sort="Boneca, Ivo G" uniqKey="Boneca I" first="Ivo G" last="Boneca">Ivo G. Boneca</name>
<affiliation wicri:level="3">
<nlm:affiliation>Institut Pasteur, Unité Biologie et Génétique de la Paroi Bactérienne, Paris 75015, France; INSERM, Avenir group, Paris 75015, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut Pasteur, Unité Biologie et Génétique de la Paroi Bactérienne, Paris 75015, France; INSERM, Avenir group, Paris 75015</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Île-de-France</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Sasakawa, Chihiro" sort="Sasakawa, Chihiro" uniqKey="Sasakawa C" first="Chihiro" last="Sasakawa">Chihiro Sasakawa</name>
<affiliation wicri:level="4">
<nlm:affiliation>Division of Bacterial Infection Biology, Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan; Nippon Institute for Biological Science, Tokyo 198-0024, Japan; Medical Mycology Research Center, Chiba University, Chiba 260-8673, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Division of Bacterial Infection Biology, Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan; Nippon Institute for Biological Science, Tokyo 198-0024, Japan; Medical Mycology Research Center, Chiba University, Chiba 260-8673</wicri:regionArea>
<orgName type="university">Université de Tokyo</orgName>
<placeName>
<settlement type="city">Tokyo</settlement>
<region type="province">Région de Kantō</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Philpott, Dana J" sort="Philpott, Dana J" uniqKey="Philpott D" first="Dana J" last="Philpott">Dana J. Philpott</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Immunology, University of Toronto, Toronto, ON M5S 1A8, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Immunology, University of Toronto, Toronto, ON M5S 1A8</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Ferrero, Richard L" sort="Ferrero, Richard L" uniqKey="Ferrero R" first="Richard L" last="Ferrero">Richard L. Ferrero</name>
<affiliation wicri:level="1">
<nlm:affiliation>Centre for Innate Immunity and Infectious Diseases, Monash Institute of Medical Research, Clayton, VIC 3168, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Centre for Innate Immunity and Infectious Diseases, Monash Institute of Medical Research, Clayton, VIC 3168</wicri:regionArea>
<wicri:noRegion>VIC 3168</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Kaparakis Liaskos, Maria" sort="Kaparakis Liaskos, Maria" uniqKey="Kaparakis Liaskos M" first="Maria" last="Kaparakis-Liaskos">Maria Kaparakis-Liaskos</name>
<affiliation wicri:level="1">
<nlm:affiliation>Centre for Innate Immunity and Infectious Diseases, Monash Institute of Medical Research, Clayton, VIC 3168, Australia. Electronic address: maria.liaskos@monash.edu.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Centre for Innate Immunity and Infectious Diseases, Monash Institute of Medical Research, Clayton, VIC 3168</wicri:regionArea>
<wicri:noRegion>VIC 3168</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:24746552</idno>
<idno type="pmid">24746552</idno>
<idno type="doi">10.1016/j.chom.2014.04.001</idno>
<idno type="wicri:Area/PubMed/Corpus">003777</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003777</idno>
<idno type="wicri:Area/PubMed/Curation">003663</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003663</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003663</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003663</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">The immune receptor NOD1 and kinase RIP2 interact with bacterial peptidoglycan on early endosomes to promote autophagy and inflammatory signaling.</title>
<author>
<name sortKey="Irving, Aaron T" sort="Irving, Aaron T" uniqKey="Irving A" first="Aaron T" last="Irving">Aaron T. Irving</name>
<affiliation wicri:level="1">
<nlm:affiliation>Centre for Cancer Research, Monash Institute of Medical Research, Clayton, VIC 3168, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Centre for Cancer Research, Monash Institute of Medical Research, Clayton, VIC 3168</wicri:regionArea>
<wicri:noRegion>VIC 3168</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Mimuro, Hitomi" sort="Mimuro, Hitomi" uniqKey="Mimuro H" first="Hitomi" last="Mimuro">Hitomi Mimuro</name>
<affiliation wicri:level="4">
<nlm:affiliation>Division of Bacteriology, Department of Infectious Diseases Control, International Research Center for Infectious Diseases, Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Division of Bacteriology, Department of Infectious Diseases Control, International Research Center for Infectious Diseases, Institute of Medical Science, The University of Tokyo, Tokyo 108-8639</wicri:regionArea>
<placeName>
<settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
<settlement type="city">Tokyo</settlement>
</placeName>
<orgName type="university">Université de Tokyo</orgName>
</affiliation>
</author>
<author>
<name sortKey="Kufer, Thomas A" sort="Kufer, Thomas A" uniqKey="Kufer T" first="Thomas A" last="Kufer">Thomas A. Kufer</name>
<affiliation wicri:level="3">
<nlm:affiliation>Institute for Medical Microbiology, Immunology and Hygiene, University of Cologne, Köln 50931, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Institute for Medical Microbiology, Immunology and Hygiene, University of Cologne, Köln 50931</wicri:regionArea>
<placeName>
<region type="land" nuts="1">Rhénanie-du-Nord-Westphalie</region>
<region type="district" nuts="2">District de Cologne</region>
<settlement type="city">Cologne</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Lo, Camden" sort="Lo, Camden" uniqKey="Lo C" first="Camden" last="Lo">Camden Lo</name>
<affiliation wicri:level="1">
<nlm:affiliation>Monash Micro Imaging, Clayton, VIC 3168, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Monash Micro Imaging, Clayton, VIC 3168</wicri:regionArea>
<wicri:noRegion>VIC 3168</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Wheeler, Richard" sort="Wheeler, Richard" uniqKey="Wheeler R" first="Richard" last="Wheeler">Richard Wheeler</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institut Pasteur, Unité Biologie et Génétique de la Paroi Bactérienne, Paris 75015, France; INSERM, Avenir group, Paris 75015, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut Pasteur, Unité Biologie et Génétique de la Paroi Bactérienne, Paris 75015, France; INSERM, Avenir group, Paris 75015</wicri:regionArea>
<wicri:noRegion>75015</wicri:noRegion>
<placeName>
<settlement type="city">Paris</settlement>
<region type="région" nuts="2">Île-de-France</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Turner, Lorinda J" sort="Turner, Lorinda J" uniqKey="Turner L" first="Lorinda J" last="Turner">Lorinda J. Turner</name>
<affiliation wicri:level="1">
<nlm:affiliation>Centre for Innate Immunity and Infectious Diseases, Monash Institute of Medical Research, Clayton, VIC 3168, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Centre for Innate Immunity and Infectious Diseases, Monash Institute of Medical Research, Clayton, VIC 3168</wicri:regionArea>
<wicri:noRegion>VIC 3168</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Thomas, Belinda J" sort="Thomas, Belinda J" uniqKey="Thomas B" first="Belinda J" last="Thomas">Belinda J. Thomas</name>
<affiliation wicri:level="1">
<nlm:affiliation>Centre for Innate Immunity and Infectious Diseases, Monash Institute of Medical Research, Clayton, VIC 3168, Australia; Monash Lung and Sleep, Monash Medical Centre, Clayton, VIC 3168, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Centre for Innate Immunity and Infectious Diseases, Monash Institute of Medical Research, Clayton, VIC 3168, Australia; Monash Lung and Sleep, Monash Medical Centre, Clayton, VIC 3168</wicri:regionArea>
<wicri:noRegion>VIC 3168</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Malosse, Christian" sort="Malosse, Christian" uniqKey="Malosse C" first="Christian" last="Malosse">Christian Malosse</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institut Pasteur, Structural Mass Spectrometry and Proteomics Unit, Paris 75015, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut Pasteur, Structural Mass Spectrometry and Proteomics Unit, Paris 75015</wicri:regionArea>
<wicri:noRegion>75015</wicri:noRegion>
<placeName>
<settlement type="city">Paris</settlement>
<region type="région" nuts="2">Île-de-France</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Gantier, Michael P" sort="Gantier, Michael P" uniqKey="Gantier M" first="Michael P" last="Gantier">Michael P. Gantier</name>
<affiliation wicri:level="1">
<nlm:affiliation>Centre for Cancer Research, Monash Institute of Medical Research, Clayton, VIC 3168, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Centre for Cancer Research, Monash Institute of Medical Research, Clayton, VIC 3168</wicri:regionArea>
<wicri:noRegion>VIC 3168</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Casillas, Linda N" sort="Casillas, Linda N" uniqKey="Casillas L" first="Linda N" last="Casillas">Linda N. Casillas</name>
<affiliation wicri:level="2">
<nlm:affiliation>Pattern Recognition Receptor Discovery Performance Unit, Immuno-Inflammation Therapy Area, GlaxoSmithKline, Collegeville, PA 19426-0989, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Pattern Recognition Receptor Discovery Performance Unit, Immuno-Inflammation Therapy Area, GlaxoSmithKline, Collegeville, PA 19426-0989</wicri:regionArea>
<placeName>
<region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Votta, Bartholomew J" sort="Votta, Bartholomew J" uniqKey="Votta B" first="Bartholomew J" last="Votta">Bartholomew J. Votta</name>
<affiliation wicri:level="2">
<nlm:affiliation>Pattern Recognition Receptor Discovery Performance Unit, Immuno-Inflammation Therapy Area, GlaxoSmithKline, Collegeville, PA 19426-0989, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Pattern Recognition Receptor Discovery Performance Unit, Immuno-Inflammation Therapy Area, GlaxoSmithKline, Collegeville, PA 19426-0989</wicri:regionArea>
<placeName>
<region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Bertin, John" sort="Bertin, John" uniqKey="Bertin J" first="John" last="Bertin">John Bertin</name>
<affiliation wicri:level="2">
<nlm:affiliation>Pattern Recognition Receptor Discovery Performance Unit, Immuno-Inflammation Therapy Area, GlaxoSmithKline, Collegeville, PA 19426-0989, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Pattern Recognition Receptor Discovery Performance Unit, Immuno-Inflammation Therapy Area, GlaxoSmithKline, Collegeville, PA 19426-0989</wicri:regionArea>
<placeName>
<region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Boneca, Ivo G" sort="Boneca, Ivo G" uniqKey="Boneca I" first="Ivo G" last="Boneca">Ivo G. Boneca</name>
<affiliation wicri:level="3">
<nlm:affiliation>Institut Pasteur, Unité Biologie et Génétique de la Paroi Bactérienne, Paris 75015, France; INSERM, Avenir group, Paris 75015, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut Pasteur, Unité Biologie et Génétique de la Paroi Bactérienne, Paris 75015, France; INSERM, Avenir group, Paris 75015</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Île-de-France</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Sasakawa, Chihiro" sort="Sasakawa, Chihiro" uniqKey="Sasakawa C" first="Chihiro" last="Sasakawa">Chihiro Sasakawa</name>
<affiliation wicri:level="4">
<nlm:affiliation>Division of Bacterial Infection Biology, Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan; Nippon Institute for Biological Science, Tokyo 198-0024, Japan; Medical Mycology Research Center, Chiba University, Chiba 260-8673, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Division of Bacterial Infection Biology, Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan; Nippon Institute for Biological Science, Tokyo 198-0024, Japan; Medical Mycology Research Center, Chiba University, Chiba 260-8673</wicri:regionArea>
<orgName type="university">Université de Tokyo</orgName>
<placeName>
<settlement type="city">Tokyo</settlement>
<region type="province">Région de Kantō</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Philpott, Dana J" sort="Philpott, Dana J" uniqKey="Philpott D" first="Dana J" last="Philpott">Dana J. Philpott</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Immunology, University of Toronto, Toronto, ON M5S 1A8, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Immunology, University of Toronto, Toronto, ON M5S 1A8</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Ferrero, Richard L" sort="Ferrero, Richard L" uniqKey="Ferrero R" first="Richard L" last="Ferrero">Richard L. Ferrero</name>
<affiliation wicri:level="1">
<nlm:affiliation>Centre for Innate Immunity and Infectious Diseases, Monash Institute of Medical Research, Clayton, VIC 3168, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Centre for Innate Immunity and Infectious Diseases, Monash Institute of Medical Research, Clayton, VIC 3168</wicri:regionArea>
<wicri:noRegion>VIC 3168</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Kaparakis Liaskos, Maria" sort="Kaparakis Liaskos, Maria" uniqKey="Kaparakis Liaskos M" first="Maria" last="Kaparakis-Liaskos">Maria Kaparakis-Liaskos</name>
<affiliation wicri:level="1">
<nlm:affiliation>Centre for Innate Immunity and Infectious Diseases, Monash Institute of Medical Research, Clayton, VIC 3168, Australia. Electronic address: maria.liaskos@monash.edu.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Centre for Innate Immunity and Infectious Diseases, Monash Institute of Medical Research, Clayton, VIC 3168</wicri:regionArea>
<wicri:noRegion>VIC 3168</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Cell host & microbe</title>
<idno type="eISSN">1934-6069</idno>
<imprint>
<date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>Autophagy</term>
<term>Cell Line</term>
<term>Endosomes (immunology)</term>
<term>Endosomes (microbiology)</term>
<term>Helicobacter Infections (enzymology)</term>
<term>Helicobacter Infections (genetics)</term>
<term>Helicobacter Infections (immunology)</term>
<term>Helicobacter pylori (immunology)</term>
<term>Helicobacter pylori (physiology)</term>
<term>Humans</term>
<term>Mice</term>
<term>Nod1 Signaling Adaptor Protein (genetics)</term>
<term>Nod1 Signaling Adaptor Protein (immunology)</term>
<term>Peptidoglycan (immunology)</term>
<term>Protein Binding</term>
<term>Pseudomonas Infections (enzymology)</term>
<term>Pseudomonas Infections (genetics)</term>
<term>Pseudomonas Infections (immunology)</term>
<term>Pseudomonas aeruginosa (immunology)</term>
<term>Pseudomonas aeruginosa (physiology)</term>
<term>Receptor-Interacting Protein Serine-Threonine Kinase 2 (genetics)</term>
<term>Receptor-Interacting Protein Serine-Threonine Kinase 2 (immunology)</term>
<term>Receptors, Immunologic (genetics)</term>
<term>Receptors, Immunologic (immunology)</term>
<term>Signal Transduction</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Animaux</term>
<term>Autophagie</term>
<term>Endosomes (immunologie)</term>
<term>Endosomes (microbiologie)</term>
<term>Helicobacter pylori (immunologie)</term>
<term>Helicobacter pylori (physiologie)</term>
<term>Humains</term>
<term>Infections à Helicobacter (enzymologie)</term>
<term>Infections à Helicobacter (génétique)</term>
<term>Infections à Helicobacter (immunologie)</term>
<term>Infections à Pseudomonas (enzymologie)</term>
<term>Infections à Pseudomonas (génétique)</term>
<term>Infections à Pseudomonas (immunologie)</term>
<term>Liaison aux protéines</term>
<term>Lignée cellulaire</term>
<term>Peptidoglycane (immunologie)</term>
<term>Protéine adaptatrice de signalisation NOD1 (génétique)</term>
<term>Protéine adaptatrice de signalisation NOD1 (immunologie)</term>
<term>Pseudomonas aeruginosa (immunologie)</term>
<term>Pseudomonas aeruginosa (physiologie)</term>
<term>Receptor-Interacting Protein Serine-Threonine Kinase 2 (génétique)</term>
<term>Receptor-Interacting Protein Serine-Threonine Kinase 2 (immunologie)</term>
<term>Récepteurs immunologiques (génétique)</term>
<term>Récepteurs immunologiques (immunologie)</term>
<term>Souris</term>
<term>Transduction du signal</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>Nod1 Signaling Adaptor Protein</term>
<term>Receptor-Interacting Protein Serine-Threonine Kinase 2</term>
<term>Receptors, Immunologic</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymologie" xml:lang="fr">
<term>Infections à Helicobacter</term>
<term>Infections à Pseudomonas</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymology" xml:lang="en">
<term>Helicobacter Infections</term>
<term>Pseudomonas Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Helicobacter Infections</term>
<term>Pseudomonas Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>Infections à Helicobacter</term>
<term>Infections à Pseudomonas</term>
<term>Protéine adaptatrice de signalisation NOD1</term>
<term>Receptor-Interacting Protein Serine-Threonine Kinase 2</term>
<term>Récepteurs immunologiques</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr">
<term>Endosomes</term>
<term>Helicobacter pylori</term>
<term>Infections à Helicobacter</term>
<term>Infections à Pseudomonas</term>
<term>Peptidoglycane</term>
<term>Protéine adaptatrice de signalisation NOD1</term>
<term>Pseudomonas aeruginosa</term>
<term>Receptor-Interacting Protein Serine-Threonine Kinase 2</term>
<term>Récepteurs immunologiques</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en">
<term>Endosomes</term>
<term>Helicobacter Infections</term>
<term>Helicobacter pylori</term>
<term>Nod1 Signaling Adaptor Protein</term>
<term>Peptidoglycan</term>
<term>Pseudomonas Infections</term>
<term>Pseudomonas aeruginosa</term>
<term>Receptor-Interacting Protein Serine-Threonine Kinase 2</term>
<term>Receptors, Immunologic</term>
</keywords>
<keywords scheme="MESH" qualifier="microbiologie" xml:lang="fr">
<term>Endosomes</term>
</keywords>
<keywords scheme="MESH" qualifier="microbiology" xml:lang="en">
<term>Endosomes</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr">
<term>Helicobacter pylori</term>
<term>Pseudomonas aeruginosa</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>Helicobacter pylori</term>
<term>Pseudomonas aeruginosa</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Autophagy</term>
<term>Cell Line</term>
<term>Humans</term>
<term>Mice</term>
<term>Protein Binding</term>
<term>Signal Transduction</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Autophagie</term>
<term>Humains</term>
<term>Liaison aux protéines</term>
<term>Lignée cellulaire</term>
<term>Souris</term>
<term>Transduction du signal</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The intracellular innate immune receptor NOD1 detects Gram-negative bacterial peptidoglycan (PG) to induce autophagy and inflammatory responses in host cells. To date, the intracellular compartment in which PG is detected by NOD1 and whether NOD1 directly interacts with PG are two questions that remain to be resolved. To address this, we used outer membrane vesicles (OMVs) from pathogenic bacteria as a physiological mechanism to deliver PG into the host cell cytosol. We report that OMVs induced autophagosome formation and inflammatory IL-8 responses in epithelial cells in a NOD1- and RIP2-dependent manner. PG contained within OMVs colocalized with both NOD1 and RIP2 in EEA1-positive early endosomes. Further, we provide evidence for direct interactions between NOD1 and PG. Collectively, these findings demonstrate that NOD1 detects PG within early endosomes, thereby promoting RIP2-dependent autophagy and inflammatory signaling in response to bacterial infection.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">24746552</PMID>
<DateCreated>
<Year>2014</Year>
<Month>05</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>01</Month>
<Day>09</Day>
</DateCompleted>
<DateRevised>
<Year>2014</Year>
<Month>05</Month>
<Day>16</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1934-6069</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>15</Volume>
<Issue>5</Issue>
<PubDate>
<Year>2014</Year>
<Month>May</Month>
<Day>14</Day>
</PubDate>
</JournalIssue>
<Title>Cell host & microbe</Title>
<ISOAbbreviation>Cell Host Microbe</ISOAbbreviation>
</Journal>
<ArticleTitle>The immune receptor NOD1 and kinase RIP2 interact with bacterial peptidoglycan on early endosomes to promote autophagy and inflammatory signaling.</ArticleTitle>
<Pagination>
<MedlinePgn>623-35</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.chom.2014.04.001</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S1931-3128(14)00135-8</ELocationID>
<Abstract>
<AbstractText>The intracellular innate immune receptor NOD1 detects Gram-negative bacterial peptidoglycan (PG) to induce autophagy and inflammatory responses in host cells. To date, the intracellular compartment in which PG is detected by NOD1 and whether NOD1 directly interacts with PG are two questions that remain to be resolved. To address this, we used outer membrane vesicles (OMVs) from pathogenic bacteria as a physiological mechanism to deliver PG into the host cell cytosol. We report that OMVs induced autophagosome formation and inflammatory IL-8 responses in epithelial cells in a NOD1- and RIP2-dependent manner. PG contained within OMVs colocalized with both NOD1 and RIP2 in EEA1-positive early endosomes. Further, we provide evidence for direct interactions between NOD1 and PG. Collectively, these findings demonstrate that NOD1 detects PG within early endosomes, thereby promoting RIP2-dependent autophagy and inflammatory signaling in response to bacterial infection.</AbstractText>
<CopyrightInformation>Copyright © 2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Irving</LastName>
<ForeName>Aaron T</ForeName>
<Initials>AT</Initials>
<AffiliationInfo>
<Affiliation>Centre for Cancer Research, Monash Institute of Medical Research, Clayton, VIC 3168, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mimuro</LastName>
<ForeName>Hitomi</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Division of Bacteriology, Department of Infectious Diseases Control, International Research Center for Infectious Diseases, Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kufer</LastName>
<ForeName>Thomas A</ForeName>
<Initials>TA</Initials>
<AffiliationInfo>
<Affiliation>Institute for Medical Microbiology, Immunology and Hygiene, University of Cologne, Köln 50931, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lo</LastName>
<ForeName>Camden</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Monash Micro Imaging, Clayton, VIC 3168, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wheeler</LastName>
<ForeName>Richard</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Institut Pasteur, Unité Biologie et Génétique de la Paroi Bactérienne, Paris 75015, France; INSERM, Avenir group, Paris 75015, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Turner</LastName>
<ForeName>Lorinda J</ForeName>
<Initials>LJ</Initials>
<AffiliationInfo>
<Affiliation>Centre for Innate Immunity and Infectious Diseases, Monash Institute of Medical Research, Clayton, VIC 3168, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Thomas</LastName>
<ForeName>Belinda J</ForeName>
<Initials>BJ</Initials>
<AffiliationInfo>
<Affiliation>Centre for Innate Immunity and Infectious Diseases, Monash Institute of Medical Research, Clayton, VIC 3168, Australia; Monash Lung and Sleep, Monash Medical Centre, Clayton, VIC 3168, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Malosse</LastName>
<ForeName>Christian</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Institut Pasteur, Structural Mass Spectrometry and Proteomics Unit, Paris 75015, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gantier</LastName>
<ForeName>Michael P</ForeName>
<Initials>MP</Initials>
<AffiliationInfo>
<Affiliation>Centre for Cancer Research, Monash Institute of Medical Research, Clayton, VIC 3168, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Casillas</LastName>
<ForeName>Linda N</ForeName>
<Initials>LN</Initials>
<AffiliationInfo>
<Affiliation>Pattern Recognition Receptor Discovery Performance Unit, Immuno-Inflammation Therapy Area, GlaxoSmithKline, Collegeville, PA 19426-0989, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Votta</LastName>
<ForeName>Bartholomew J</ForeName>
<Initials>BJ</Initials>
<AffiliationInfo>
<Affiliation>Pattern Recognition Receptor Discovery Performance Unit, Immuno-Inflammation Therapy Area, GlaxoSmithKline, Collegeville, PA 19426-0989, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bertin</LastName>
<ForeName>John</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Pattern Recognition Receptor Discovery Performance Unit, Immuno-Inflammation Therapy Area, GlaxoSmithKline, Collegeville, PA 19426-0989, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Boneca</LastName>
<ForeName>Ivo G</ForeName>
<Initials>IG</Initials>
<AffiliationInfo>
<Affiliation>Institut Pasteur, Unité Biologie et Génétique de la Paroi Bactérienne, Paris 75015, France; INSERM, Avenir group, Paris 75015, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sasakawa</LastName>
<ForeName>Chihiro</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Division of Bacterial Infection Biology, Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan; Nippon Institute for Biological Science, Tokyo 198-0024, Japan; Medical Mycology Research Center, Chiba University, Chiba 260-8673, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Philpott</LastName>
<ForeName>Dana J</ForeName>
<Initials>DJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Immunology, University of Toronto, Toronto, ON M5S 1A8, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ferrero</LastName>
<ForeName>Richard L</ForeName>
<Initials>RL</Initials>
<AffiliationInfo>
<Affiliation>Centre for Innate Immunity and Infectious Diseases, Monash Institute of Medical Research, Clayton, VIC 3168, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kaparakis-Liaskos</LastName>
<ForeName>Maria</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Centre for Innate Immunity and Infectious Diseases, Monash Institute of Medical Research, Clayton, VIC 3168, Australia. Electronic address: maria.liaskos@monash.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>04</Month>
<Day>17</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Cell Host Microbe</MedlineTA>
<NlmUniqueID>101302316</NlmUniqueID>
<ISSNLinking>1931-3128</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D053474">Nod1 Signaling Adaptor Protein</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D010457">Peptidoglycan</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011971">Receptors, Immunologic</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.11.1</RegistryNumber>
<NameOfSubstance UI="C506253">RIPK2 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.11.1</RegistryNumber>
<NameOfSubstance UI="D053475">Receptor-Interacting Protein Serine-Threonine Kinase 2</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001343" MajorTopicYN="Y">Autophagy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011992" MajorTopicYN="N">Endosomes</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016481" MajorTopicYN="N">Helicobacter Infections</DescriptorName>
<QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016480" MajorTopicYN="N">Helicobacter pylori</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D053474" MajorTopicYN="N">Nod1 Signaling Adaptor Protein</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010457" MajorTopicYN="N">Peptidoglycan</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011552" MajorTopicYN="N">Pseudomonas Infections</DescriptorName>
<QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011550" MajorTopicYN="N">Pseudomonas aeruginosa</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D053475" MajorTopicYN="N">Receptor-Interacting Protein Serine-Threonine Kinase 2</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011971" MajorTopicYN="N">Receptors, Immunologic</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2014</Year>
<Month>01</Month>
<Day>02</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2014</Year>
<Month>03</Month>
<Day>31</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2014</Year>
<Month>04</Month>
<Day>03</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2014</Year>
<Month>4</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2014</Year>
<Month>4</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2015</Year>
<Month>1</Month>
<Day>13</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">24746552</ArticleId>
<ArticleId IdType="pii">S1931-3128(14)00135-8</ArticleId>
<ArticleId IdType="doi">10.1016/j.chom.2014.04.001</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Allemagne</li>
<li>Australie</li>
<li>Canada</li>
<li>France</li>
<li>Japon</li>
<li>États-Unis</li>
</country>
<region>
<li>District de Cologne</li>
<li>Ontario</li>
<li>Pennsylvanie</li>
<li>Rhénanie-du-Nord-Westphalie</li>
<li>Région de Kantō</li>
<li>Île-de-France</li>
</region>
<settlement>
<li>Cologne</li>
<li>Paris</li>
<li>Tokyo</li>
<li>Toronto</li>
</settlement>
<orgName>
<li>Université de Tokyo</li>
<li>Université de Toronto</li>
</orgName>
</list>
<tree>
<country name="Australie">
<noRegion>
<name sortKey="Irving, Aaron T" sort="Irving, Aaron T" uniqKey="Irving A" first="Aaron T" last="Irving">Aaron T. Irving</name>
</noRegion>
<name sortKey="Ferrero, Richard L" sort="Ferrero, Richard L" uniqKey="Ferrero R" first="Richard L" last="Ferrero">Richard L. Ferrero</name>
<name sortKey="Gantier, Michael P" sort="Gantier, Michael P" uniqKey="Gantier M" first="Michael P" last="Gantier">Michael P. Gantier</name>
<name sortKey="Kaparakis Liaskos, Maria" sort="Kaparakis Liaskos, Maria" uniqKey="Kaparakis Liaskos M" first="Maria" last="Kaparakis-Liaskos">Maria Kaparakis-Liaskos</name>
<name sortKey="Lo, Camden" sort="Lo, Camden" uniqKey="Lo C" first="Camden" last="Lo">Camden Lo</name>
<name sortKey="Thomas, Belinda J" sort="Thomas, Belinda J" uniqKey="Thomas B" first="Belinda J" last="Thomas">Belinda J. Thomas</name>
<name sortKey="Turner, Lorinda J" sort="Turner, Lorinda J" uniqKey="Turner L" first="Lorinda J" last="Turner">Lorinda J. Turner</name>
</country>
<country name="Japon">
<region name="Région de Kantō">
<name sortKey="Mimuro, Hitomi" sort="Mimuro, Hitomi" uniqKey="Mimuro H" first="Hitomi" last="Mimuro">Hitomi Mimuro</name>
</region>
<name sortKey="Sasakawa, Chihiro" sort="Sasakawa, Chihiro" uniqKey="Sasakawa C" first="Chihiro" last="Sasakawa">Chihiro Sasakawa</name>
</country>
<country name="Allemagne">
<region name="Rhénanie-du-Nord-Westphalie">
<name sortKey="Kufer, Thomas A" sort="Kufer, Thomas A" uniqKey="Kufer T" first="Thomas A" last="Kufer">Thomas A. Kufer</name>
</region>
</country>
<country name="France">
<region name="Île-de-France">
<name sortKey="Wheeler, Richard" sort="Wheeler, Richard" uniqKey="Wheeler R" first="Richard" last="Wheeler">Richard Wheeler</name>
</region>
<name sortKey="Boneca, Ivo G" sort="Boneca, Ivo G" uniqKey="Boneca I" first="Ivo G" last="Boneca">Ivo G. Boneca</name>
<name sortKey="Malosse, Christian" sort="Malosse, Christian" uniqKey="Malosse C" first="Christian" last="Malosse">Christian Malosse</name>
</country>
<country name="États-Unis">
<region name="Pennsylvanie">
<name sortKey="Casillas, Linda N" sort="Casillas, Linda N" uniqKey="Casillas L" first="Linda N" last="Casillas">Linda N. Casillas</name>
</region>
<name sortKey="Bertin, John" sort="Bertin, John" uniqKey="Bertin J" first="John" last="Bertin">John Bertin</name>
<name sortKey="Votta, Bartholomew J" sort="Votta, Bartholomew J" uniqKey="Votta B" first="Bartholomew J" last="Votta">Bartholomew J. Votta</name>
</country>
<country name="Canada">
<region name="Ontario">
<name sortKey="Philpott, Dana J" sort="Philpott, Dana J" uniqKey="Philpott D" first="Dana J" last="Philpott">Dana J. Philpott</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003130 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 003130 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:24746552
   |texte=   The immune receptor NOD1 and kinase RIP2 interact with bacterial peptidoglycan on early endosomes to promote autophagy and inflammatory signaling.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:24746552" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a AustralieFrV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024